Management of Suspected Encephalitis
Immediate Empirical Treatment
Start intravenous acyclovir (10 mg/kg every 8 hours) immediately in all patients with suspected encephalitis, as soon as possible after presentation, without waiting for diagnostic confirmation. 1 This recommendation is based on randomized controlled trials demonstrating that acyclovir reduces mortality in HSV encephalitis from >70% to 20-30%, with outcomes dramatically better when treatment begins within 48 hours of hospital admission. 1
Dosing Specifications
- Adults and children with normal renal function: 10 mg/kg IV every 8 hours 1
- Neonates: 20 mg/kg IV every 8 hours 1
- Adjust dose in renal impairment 1, 2
- Duration: 14-21 days for confirmed HSV encephalitis 1
- Immunocompromised patients: Treat for at least 21 days, then reassess with CSF PCR 1
Critical Timing Considerations
The 6-hour window is crucial: if CSF results or imaging will not be available within 6 hours of admission, or if the patient is severely ill or deteriorating, start acyclovir immediately. 1 Mortality drops to 8% when acyclovir is initiated within 4 days of symptom onset, compared to 28% overall mortality at 18 months. 1
Additional Empirical Antimicrobials
- Add antibiotics for bacterial meningitis if clinically indicated (altered mental status with fever, meningismus, or CSF pleocytosis suggesting bacterial infection) 1
- Add doxycycline if rickettsial or ehrlichial infection suspected based on season, tick exposure, or rash 1
Urgent Diagnostic Workup (Parallel to Treatment)
Lumbar Puncture - Perform Immediately Unless Contraindicated
Obtain CSF as soon as possible after hospital admission 1, 3, but delay only if: 1
- Signs of raised intracranial pressure (papilledema, focal neurological deficits suggesting mass effect)
- Coagulopathy
- Significant brain shift on imaging
CSF studies required: 1
- Cell count with differential
- Protein and glucose
- HSV-1 and HSV-2 PCR (results should be available within 24-48 hours) 1, 3
- VZV PCR 1
- Enterovirus PCR 1
- Bacterial culture and Gram stain
- Consider: West Nile virus PCR, arbovirus serology based on epidemiology 1
Neuroimaging - Within 24 Hours
MRI brain is strongly preferred over CT (detects early changes in 90% of HSV encephalitis cases versus only 25% for CT) 4, 3. Perform under general anesthesia if needed for patient cooperation. 3
EEG - Within 24 Hours
Obtain EEG to assess for seizure activity and characteristic patterns (temporal lobe abnormalities in HSV encephalitis). 1, 3
Autoimmune Encephalitis Evaluation
Send autoimmune antibody panel from both serum and CSF simultaneously with infectious workup: 3
- NMDA receptor antibodies
- Voltage-gated potassium channel complex antibodies
- LGI1, CASPR2, IGLON5 antibodies
- Other neuronal surface and intracellular antibodies 3
Do not delay empirical acyclovir while awaiting autoimmune results, as HSV and autoimmune encephalitis can have overlapping presentations. 3
Critical Care Management
ICU Assessment Required for:
- Declining level of consciousness 1, 4, 3
- Glasgow Coma Score <6 1
- Respiratory compromise
- Hemodynamic instability
ICU Interventions: 1, 4, 3
- Airway protection and ventilatory support
- Management of raised intracranial pressure and optimization of cerebral perfusion pressure
- Correction of electrolyte imbalances (particularly hyponatremia, which is common) 5
- Seizure management: Use IV levetiracetam (30-60 mg/kg/day) or IV valproate (20-30 mg/kg loading dose); avoid phenytoin as first-line 4
Transfer to Neuroscience Center
Transfer within 24 hours if: 1, 3
- Diagnosis not rapidly established
- Patient fails to improve with initial therapy
- Need for neurosurgical consultation
Etiology-Specific Treatment Adjustments
If HSV PCR Returns Negative but Clinical Suspicion Remains High
Repeat CSF PCR 3-7 days later on a second specimen, as initial PCR can be falsely negative if performed very early. 1 Continue acyclovir until repeat testing completed. 1
If Autoimmune Encephalitis Confirmed or Strongly Suspected
Initiate first-line immunotherapy immediately after excluding active infection: 3
- High-dose IV methylprednisolone 1g daily for 3-5 days 4, 3
- Plus IVIG 0.4 g/kg/day for 5 days 4, 3
- Continue immunosuppression with gradual oral prednisone taper or monthly IVIG to prevent relapse 3
For Paraneoplastic Encephalitis
Search for occult malignancy with CT or PET scan of chest, abdomen, and pelvis. 4 Treat underlying tumor when identified. 4
For Returning Travelers
- Test for malaria with rapid antigen tests and three thick/thin blood films if returning from endemic areas 1
- Consider cerebral malaria treatment if high suspicion and delay in film results 1
- Evaluate for Japanese encephalitis, dengue, or other geographically relevant pathogens 1
Common Pitfalls to Avoid
Do not wait for LP or imaging results to start acyclovir if there will be any delay beyond 6 hours or if patient is deteriorating 1, 3
Do not rely on negative CSF PCR to exclude HSV encephalitis if performed very early; repeat testing may be needed 1
Do not use CT brain alone - MRI is far superior for detecting early encephalitic changes 4, 3
Do not delay immunotherapy while awaiting antibody results if autoimmune encephalitis is suspected and infection has been reasonably excluded 3
Predictors of poor outcome include: age >30 years, Glasgow Coma Score <6, and delay >4 days before starting acyclovir 1 - emphasizing the critical importance of early treatment
Brain Biopsy - Reserved for Specific Situations
Consider stereotactic brain biopsy only if: 1
- Patient is HSV PCR-negative and deteriorates despite acyclovir
- Focal lesion on imaging suggests alternative diagnosis
- No diagnosis established after comprehensive workup
Modern stereotactic approaches have low complication rates, and biopsy identifies alternative treatable diagnoses in 20% of suspected HSV cases. 1
Discharge Planning and Rehabilitation
Never discharge patients without: 1, 3
- Definitive or suspected diagnosis established
- Outpatient follow-up appointment scheduled (at least one) 1, 5, 3
- Comprehensive rehabilitation assessment arranged 1, 5, 4, 3
All patients require access to: 1, 5, 4, 3
- Neuropsychology evaluation (30-50% develop long-term cognitive deficits) 4
- Neuropsychiatry assessment (anxiety, depression, obsessive behaviors common) 1, 4
- Speech and language therapy
- Neurophysiotherapy
- Occupational therapy
Sequelae may not be immediately apparent at discharge - structured follow-up is essential to identify delayed neurological and psychiatric complications. 1, 5, 4